Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Rasmussen

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Leukemia|April 23, 2020
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myelomaHans C Lee, Noopur S Raje, Ola Landgren, et al.
Blood|December 3, 2005
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapiesBart Barlogie, Guido Tricot, Erik Rasmussen, et al.
Cancer Chemotherapy and Pharmacology|January 3, 2012
Exposure-response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selectionJian-Feng Lu, Erik Rasmussen, Beth Y Karlan, et al.
Journal for Immunotherapy of Cancer|September 27, 2018
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumorsBen Tran, Richard D Carvajal, Aurelien Marabelle, et al.
Chiropractic & Manual Therapies|March 25, 2021
Categorisation of lumbar spine MRI referrals in Denmark as compliant or non-compliant to international imaging guidelines: an inter-rater reliability studySusanne Brogaard Krogh, Tue Secher Jensen, Nanna Rolving, et al.
The Journal of Trauma and Acute Care Surgery|January 28, 2016
A systematic review of the use of resuscitative endovascular balloon occlusion of the aorta in the management of hemorrhagic shockJonathan J Morrison, Jonathan James Morrison, Richard E Galgon, et al.
Toxicologic Pathology|April 17, 2008
Temporal gene expression profiling indicates early up-regulation of interleukin-6 in isoproterenol-induced myocardial necrosis in ratIgor Mikaelian, Denise Coluccio, Kevin T Morgan, et al.
Blood Advances|June 30, 2019
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemiaHarry P Erba, Pamela S Becker, Paul J Shami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2017
First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid TumorsKyriakos P Papadopoulos, Larry Gluck, Lainie P Martin, et al.
Investigational New Drugs|April 22, 2015
Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumorsJennifer R Diamond, Benjamin Wu, Neeraj Agarwal, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Leukemia|April 23, 2020
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myelomaHans C Lee, Noopur S Raje, Ola Landgren, et al.
Blood|December 3, 2005
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapiesBart Barlogie, Guido Tricot, Erik Rasmussen, et al.
Cancer Chemotherapy and Pharmacology|January 3, 2012
Exposure-response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selectionJian-Feng Lu, Erik Rasmussen, Beth Y Karlan, et al.
Journal for Immunotherapy of Cancer|September 27, 2018
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumorsBen Tran, Richard D Carvajal, Aurelien Marabelle, et al.
Chiropractic & Manual Therapies|March 25, 2021
Categorisation of lumbar spine MRI referrals in Denmark as compliant or non-compliant to international imaging guidelines: an inter-rater reliability studySusanne Brogaard Krogh, Tue Secher Jensen, Nanna Rolving, et al.
The Journal of Trauma and Acute Care Surgery|January 28, 2016
A systematic review of the use of resuscitative endovascular balloon occlusion of the aorta in the management of hemorrhagic shockJonathan J Morrison, Jonathan James Morrison, Richard E Galgon, et al.
Toxicologic Pathology|April 17, 2008
Temporal gene expression profiling indicates early up-regulation of interleukin-6 in isoproterenol-induced myocardial necrosis in ratIgor Mikaelian, Denise Coluccio, Kevin T Morgan, et al.
Blood Advances|June 30, 2019
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemiaHarry P Erba, Pamela S Becker, Paul J Shami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2017
First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid TumorsKyriakos P Papadopoulos, Larry Gluck, Lainie P Martin, et al.
Investigational New Drugs|April 22, 2015
Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumorsJennifer R Diamond, Benjamin Wu, Neeraj Agarwal, et al.
Pageof 5